An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

Equity markets performed well in January, as they often do, but as the dust settles on that early-year run, the strategy for long-term investors remains the same: Invest in companies that can perform ...

While some of the initial zeal around localized vaccine production in Africa has waned since the height of the COVID-19 pandemic, efforts to bolster the continent’s immunization autonomy—especially | ...

Artificial intelligence (AI) is transforming various industries as a major investing theme in 2025. The technology's ability ...

The VDH and Scott are advocating for people to get their vaccinations before winter. Scott said he has received his COVID ...

The S&P 500 fell 0.8% on Monday, Feb. 3, as investors reacted to tariffs on major U.S. trading partners while awaiting key ...

SiriusXM’s Megyn Kelly said Friday during her show that she would be watching Republican Louisiana Sen. Bill Cassidy’s vote ...

Diane Meyer “didn’t feel a thing” as she rolled up her sleeve and received her coronavirus shot in the makeshift “vaccination station” Thursday at Cornerstone Church in Litchfield. In fact, ...

As Moderna maps out a more cautious future amid lower-than-expected sales of its current products, the company is bolstering ...

Welcome to the Merck & Company Q4 sales and earnings conference call. [Operator instructions] This call is being recorded.

"GSK brings this suit to recover a reasonable royalty for Moderna's infringing sales of mRNA vaccines that apply the Mandl team's inventions." Sales of COVID-19 vaccine are in steep decline from ...

Robert F. Kennedy Jr.'s candidacy for Secretary of Health and Human Services in US President Donald Trump's new administration received a boost on Tuesday when the US Senate Committee on Finance voted ...